Human Papillomavirus (HPV) – Cervical Cancer Screening

99% of cervical cancer cases are caused by the Human Papillomavirus (HPV).

HPV is a sexually transmitted infection. Infection can occur during any type of sexual contact, including protected intercourse.

While HPV most commonly causes cervical cancer, it can also damage other organs, such as the vagina, vulva, and anus. In men, it is frequently the cause of throat, anal, penile, and oral cancers.

There are more than 200 subtypes of HPV. Among them, 14 subtypes are particularly significant as they can cause cervical cancer; these are known as high-risk subtypes.

The “Mrcheveli” local laboratory performs screening for high-risk HPV subtypes using the PCR (Polymerase Chain Reaction) method.

High-risk HPV screening covers the following subtypes: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. If any of these subtypes are detected during the study, the result will indicate a “Positive” status.

Additional Clinical Value of the Test: If any of the following three subtypes (16, 18, or 45) are detected, the specific subtype name will be provided alongside the positive status. For example:

  • Subtype 16 Positive – means the patient is infected with HPV subtype 16.

  • Subtype 18/45 Positive – means the patient is infected with HPV subtype 18 and/or 45.

  • Other High-Risk Subtypes Positive – means at least one of the other high-risk subtypes (31, 33, 35, 39, 51, 52, 56, 58, 59, 66, 68) is present.

Through timely detection of HPV and appropriate medical supervision, cervical cancer can be prevented.


To schedule an appointment for specimen collection, please contact us: 📞 2931000, 2378848, 599931000

Book a Lab
Appointment